NICE guidance in schizophrenia: How generalisable are drug trials?
Aims and method: To test the National Institute for Clinical Excellence (NICE) assertion that characteristics of participants in the majority of clinical drug trials in schizophrenia do not reflect clinical practice. In particular they were concerned about the relative exclusion of women, older adul...
Main Author: | Burns, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2006
|
Similar Items
-
Diagnosis and management of endometriosis: summary of NICE guidance
by: Kuznetsov, L, et al.
Published: (2017) -
Commentary: Controversies in NICE guidance on chronic kidney disease.
by: Landray, M, et al.
Published: (2008) -
Reduction in twin stillbirth following implementation of NICE guidance
by: Khalil, A, et al.
Published: (2020) -
Commentary: Controversies in NICE guidance on chronic kidney disease
by: Landray, M, et al.
Published: (2008) -
Management of hip fracture in adults: summary of NICE guidance.
by: Ftouh, S, et al.
Published: (2011)